TheJobsMapAbout Ashvattha Therapeutics
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Founded in 2015 by Jeffrey Cleland, Justin Hanes, Kannan Rangaramanujam and Sujatha Kannan.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $98M
- Headquarters
- Redwood City
Leadership
The top of Ashvattha Therapeutics's org chart, with how many people report into each leader.
Jeffrey L. Cleland
Chairman, President & CEO
9 reports
S. Sakura Minami
VP Translational Medicine And Nonclinical Development
4 reports
Mehdi Paborji
Senior Vice President of Technical Operations and CMC
3 reports
Board
George Montgomery
Executive Chairman
Hamid Ghandehari
Scientific Advisor
Jay Zaveri
Board Director
Barbara Slusher
Director
Nicholas A. Peppas
Scientific Advisor
Kim Green
Scientific Advisor
Jobs at Ashvattha Therapeutics
No open positions right now. Explore more companies on TheJobsMap.